EGFR CAR mRNA-LNP
Cat. No.: TDLD-0825-LD58
EGFR CAR mRNA-LNP
EGFR CAR mRNA-LNP is a state-of-the-art messenger RNA (mRNA) lipid nanoparticle (LNP) system, specifically engineered for efficient in vitro and in vivo protein expression. This LNP encapsulates mRNA encoding the Chimeric Antigen Receptor (CAR) targeting Epidermal Growth Factor Receptor (EGFR), serving as an excellent tool for investigating targeted immunotherapies against EGFR-expressing cancers, enabling studies on CAR-T cell function and tumor cell interactions. Engineered with a proprietary lipid formulation for optimal mRNA encapsulation and delivery, it ensures high translation efficiency. Our LNP ensures uniform particle size, high encapsulation efficiency, stability, and effective delivery. Applications of EGFR CAR mRNA-LNP include evaluating CAR expression on engineered T cells and assessing their cytotoxic activity against EGFR-positive cancer cell lines. Please note that this product is intended for research purposes only.
| Payload Type | CAR mRNA |
| Payload | EGFR CAR mRNA |
| Modification | Unmodified; N1-methyl-pseudouridine; 5-methoxyuridine; Other |
| Module Type | Unconjugation |
| Lipid Formulation | SM102 |
| Dye | Unlabeled |
| Application | Gene Therapy; CAR-T |
| Format | Liquid |
| Concentration | 0.1 mg/mL; 0.2 mg/mL; Other (Please Specify) |
| Size | 65-120 nm |
| PDI | < 0.2 |
| Zeta | ± 20.0 mV |
| Encapsulate Efficiency | >90% |
| Shipping | Dry Ice |
| Storage | Store at -80°C |
Click the button below to contact us or submit your feedback about this product.
